ARS Pharmaceuticals
SPRY
#4984
Rank
โ‚น114.92 B
Marketcap
โ‚น1,183
Share price
-0.71%
Change (1 day)
213.80%
Change (1 year)

Revenue for ARS Pharmaceuticals (SPRY)

Revenue in 2024 (TTM): โ‚น41.68 Million

According to ARS Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚น42.2 Million. In 2023 the company made a revenue of โ‚น2.49 Million a decrease over the revenue in the year 2022 that were of โ‚น0.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ARS Pharmaceuticals from 2022 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น41.68 M1568.98%
2023 โ‚น2.49 M-97.71%
2022 โ‚น0.10 B